An injection of bupivacaine following Mohs micrographic surgery procedures that have notable postsurgical pain significantly reduces pain scores and, importantly, use of postsurgical narcotics, a randomized trial shows.
"Single-dose, in-office bupivacaine administration immediately following reconstructions known to be high risk for pain reduces postoperative narcotic use and acute pain during the time period when our patients have the highest levels of pain," said first author Vanessa B. Voss, MD, of the University of Missouri, in Columbia, who presented the findings at the American College of Mohs Surgery (ACMS) 2022 Annual Meeting
